big pharma take over, page-5

Hi Tassie...
Cavatak is not restricted to Melanomas..... and is being aimed at a variety of cancers. The more successful it proves to be against other forms of cancer.... the more interest it will create amongst Pharmas.

Yes.... I am not alone in believing it is worth more than T-Vec.... biased or otherwise.

It is not possible to be sold to a number of Pharmas.... it requires ONE Pharma to take it (the risk) on and advance it to Stage III trials.... costing $many millions. It is during these later stage trials that the milestones are encountered.

Hope that helps.